Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HHAT | Q5VTY9 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 2/20 | 0.31 |
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914073 | 0.72 | CTRB1 (0.37) | KDM4EALDH1A1RAB9AF2KMT2A | |
| SCHEMBL13095128 | 0.71 | HDAC4 (0.34) | KDM4EALDH1A1HTTRAB9AGAA | |
| SCHEMBL23914311 | 0.70 | CTRB1 (0.35) | RAB9AKMT2ACTRB1 | |
| SCHEMBL23914312 | 0.70 | CTRB1 (0.35) | RAB9AKMT2ACTRB1 | |
| SCHEMBL10527275 | 0.67 | RAB9A (0.44) | KDM4EALDH1A1RAB9AGAAKMT2A | |
| SCHEMBL23914286 | 0.67 | CTRB1 (0.36) | ALDH1A1KMT2ACTRB1 | |
| SCHEMBL23914260 | 0.65 | HDAC4 (0.39) | ALDH1A1GAAKMT2AMAPT | |
| SCHEMBL23914326 | 0.65 | MEN1 (0.45) | ALDH1A1KMT2AMAPT | |
| SCHEMBL23914420 | 0.62 | ALDH1A1 (0.41) | ALDH1A1HTTRAB9AKMT2AMAPT | |
| SCHEMBL23914069 | 0.62 | ALDH1A1 (0.41) | ALDH1A1HTTRAB9AKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | ADRB2 3745/4885ADRB1 2753/4885KDM4E 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.